Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13076
Cocrystal Pharma
COCP
$22M
| $47.4K | ﹤0.01% |
+45,118
| New | +$55.5K |
|
|
MBAI
13077
MBody AI Ltd. Ordinary Share
MBAI
$8.93M
| $47.2K | ﹤0.01% |
+5,390
| New | +$59.3K |
|
13078
HF Foods Group
HFFG
$92.3M
| $47K | ﹤0.01% |
+33,357
| New | +$64.5K |
|
13079
Aprea Therapeutics
APRE
$9.43M
| $47K | ﹤0.01% |
+58,600
| New | +$48.9K |
|
13080
Marygold Companies
MGLD
$40.5M
| $46.9K | ﹤0.01% |
39,408
+1,613
| +4% | +$1.83K |
|
13081
Fusion Fuel Green
HTOO
$16M
| $46.9K | ﹤0.01% |
+17,682
| New | +$53.6K |
|
13082
CALL
Information Services Group
III
$260M
| $46.9K | ﹤0.01% |
11,400
-49,300
| -81% | -$206K |
|
|
KNDI
13083
Kandi Technologies Group
KNDI
$58.7M
| $46.8K | ﹤0.01% |
65,577
-10,949
| -14% | -$8.08K |
|
|
GRSD
13084
PUT
Grandstand Ltd
GRSD
$61.2M
| $46.7K | ﹤0.01% |
24,600
-31,200
| -56% | -$97.1K |
|
|
PAPL
13085
Pineapple Financial
PAPL
$22.9M
| $46.6K | ﹤0.01% |
+46,167
| New | +$45.5K |
|
13086
Heritage Global
HGBL
$48.1M
| $46.4K | ﹤0.01% |
+38,312
| New | +$50K |
|
|
SJT
13087
PUT
San Juan Basin Royalty Trust
SJT
$140M
| $46.2K | ﹤0.01% |
14,400
-62,300
| -81% | -$251K |
|
|
GIFT
13088
Giftify Inc
GIFT
$24.8M
| $46.1K | ﹤0.01% |
+48,669
| New | +$48.4K |
|
|
GMHS
13089
Gamehaus Holdings
GMHS
$42.6M
| $46.1K | ﹤0.01% |
46,862
+10,326
| +28% | +$9.94K |
|
13090
PUT
BlackRock TCP Capital
TCPC
$336M
| $46K | ﹤0.01% |
13,700
-16,400
| -54% | -$63.7K |
|
|
OGI
13091
CALL
Organigram Holdings
OGI
$153M
| $46K | ﹤0.01% |
45,100
-82,700
| -65% | -$101K |
|
|
BLRX
13092
BioLineRX
BLRX
$12.2M
| $45.9K | ﹤0.01% |
+14,796
| New | +$42.9K |
|
|
MTR
13093
Mesa Royalty Trust
MTR
$4.6M
| $45.8K | ﹤0.01% |
14,789
+2,614
| +21% | +$10.8K |
|
|
CNTN
13094
Canton Strategic Holdings
CNTN
$163M
| $45.8K | ﹤0.01% |
+16,257
| New | +$51.4K |
|
|
ACH
13095
PUT
Accendra Health
ACH
$85.4M
| $45.8K | ﹤0.01% |
13,400
-5,000
| -27% | -$15.5K |
|
|
GME.WS
13096
GameStop Corp Warrants
GME.WS
| $45.8K | ﹤0.01% |
16,416
-179,008
| -92% | -$605K |
|
|
IH
13097
iHuman
IH
$59.3M
| $45.8K | ﹤0.01% |
32,689
+7,661
| +31% | +$12.3K |
|
13098
CALL
Stereotaxis
STXS
$132M
| $45.8K | ﹤0.01% |
26,600
+3,100
| +13% | +$5.82K |
|
|
IMRN
13099
Immuron
IMRN
$10M
| $45.7K | ﹤0.01% |
43,123
+29,319
| +212% | +$29.2K |
|
13100
NeuroOne Medical Technologies
NMTC
$13.3M
| $45.7K | ﹤0.01% |
+15,032
| New | +$61.4K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.